Clinical trial

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

NCT03623282

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Synatura® 15 mL Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-04-17

PhasePHASE4

Conditions

Bronchitis, COPDunresolved

Interventions

Synatura® 15 mLDRUG

Sponsors & collaborators

Ahn-Gook Pharmaceuticals Co.,Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03623282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.